Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation
Standard
Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation. / Haen, Sebastian P; Gouttefangeas, Cécile; Schmidt, Diethard; Boss, Andreas; Clasen, Stephan; von Herbay, Alexandra; Kosan, Bora; Aebert, Hermann; Pereira, Philippe L; Rammensee, Hans-Georg.
in: CELL STRESS CHAPERON, Jahrgang 16, Nr. 5, 09.2011, S. 495-504.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation
AU - Haen, Sebastian P
AU - Gouttefangeas, Cécile
AU - Schmidt, Diethard
AU - Boss, Andreas
AU - Clasen, Stephan
AU - von Herbay, Alexandra
AU - Kosan, Bora
AU - Aebert, Hermann
AU - Pereira, Philippe L
AU - Rammensee, Hans-Georg
PY - 2011/9
Y1 - 2011/9
N2 - Due to their adjuvant effect and their ability to chaperone tumor-associated peptides, heat shock proteins constitute a potent alarm signal for the immune system and can lead to activation of anti-tumor T-cell immunity. Radiofrequency ablation has been reported to induce heat shock protein expression especially that of heat shock protein 70 in sublethally damaged tumor cells. In this study, we evaluated the release of heat shock protein 70 into the serum of cancer-bearing patients directly after radiofrequency ablation. Sera of 22 patients undergoing radiofrequency ablation for the treatment of primary and secondary malignancies of the liver, kidney, and lung, as well as control sera of 20 patients undergoing diagnostic liver biopsy were analyzed using a manufactured heat shock protein 70 ELISA. A significant increase in serum levels of heat shock protein 70 was detectable in the patient cohort 1 day after radiofrequency ablation. More than a twofold increase was observed in nine out of 22 patients, which tended to correlate with favorable clinical outcome. No patient of the control group revealed a comparable increase. Radiofrequency ablation can lead to a release of heat shock protein 70 into the serum, which is transiently detectable 1 day after treatment. Elevated heat shock protein 70 serum levels may constitute a biomarker for favorable clinical outcome.
AB - Due to their adjuvant effect and their ability to chaperone tumor-associated peptides, heat shock proteins constitute a potent alarm signal for the immune system and can lead to activation of anti-tumor T-cell immunity. Radiofrequency ablation has been reported to induce heat shock protein expression especially that of heat shock protein 70 in sublethally damaged tumor cells. In this study, we evaluated the release of heat shock protein 70 into the serum of cancer-bearing patients directly after radiofrequency ablation. Sera of 22 patients undergoing radiofrequency ablation for the treatment of primary and secondary malignancies of the liver, kidney, and lung, as well as control sera of 20 patients undergoing diagnostic liver biopsy were analyzed using a manufactured heat shock protein 70 ELISA. A significant increase in serum levels of heat shock protein 70 was detectable in the patient cohort 1 day after radiofrequency ablation. More than a twofold increase was observed in nine out of 22 patients, which tended to correlate with favorable clinical outcome. No patient of the control group revealed a comparable increase. Radiofrequency ablation can lead to a release of heat shock protein 70 into the serum, which is transiently detectable 1 day after treatment. Elevated heat shock protein 70 serum levels may constitute a biomarker for favorable clinical outcome.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Biomarkers/metabolism
KW - Biopsy
KW - Catheter Ablation
KW - Female
KW - HSP70 Heat-Shock Proteins/blood
KW - Humans
KW - Liver/metabolism
KW - Male
KW - Middle Aged
KW - Neoplasms/metabolism
KW - Treatment Outcome
KW - Young Adult
U2 - 10.1007/s12192-011-0261-y
DO - 10.1007/s12192-011-0261-y
M3 - SCORING: Journal article
C2 - 21442384
VL - 16
SP - 495
EP - 504
JO - CELL STRESS CHAPERON
JF - CELL STRESS CHAPERON
SN - 1355-8145
IS - 5
ER -